 |
|
|
| |
Proof-of-concept study of an apoptosis-signal regulating kinase (ASK1) inhibitor (selonsertib) in combination with an acetyl-CoA carboxylase inhibitor (GS-0976) or a farnesoid X receptor (FXR) agonist (GS-9674) in NASH
|
| |
| |
Reported by Jules Levin
Oral today
EASL April 13 2018 Paris France
Eric Lawitz,1 Robert Herring,2 Ziad H. Younes,3 Edward Gane,4 Peter J. Ruane,5 Raul Aguilar,6 Catherine Jia,6 Ren Xu,6 Bryan McColgan,6 C. Stephen Djedjos,6 G. Mani Subramanian,6
John G. McHutchison,6 Robert P. Myers,6 Michael Middleton,7 Kelvin Li,8 Marc Hellerstein,8
Paul Kwo,9 Mazen Noureddin,10 Stephen A. Harrison11
|
| |
|
|
|
|
|
